Document/ExhibitDescriptionPagesSize
1: 10-K Annual Report HTML 2.04M
2: EX-4.2 EX-4.2 Description of Capital Stock HTML 34K
3: EX-10.25 EX-10.25 Employee Offer Letter HTML 39K
4: EX-21.1 EX-21.1 Subsidiaries of the Registrant HTML 26K
5: EX-23.1 EX-23.1 Consent HTML 27K
10: EX-97 EX-97 Clawback Policy HTML 46K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 30K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 30K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 27K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 27K
16: R1 Cover Page HTML 92K
17: R2 Audit Information HTML 31K
18: R3 Consolidated Balance Sheets HTML 129K
19: R4 Consolidated Balance Sheets (Parenthetical) HTML 36K
20: R5 Consolidated Statements of Operations and HTML 115K
Comprehensive Income (Loss)
21: R6 Condensed Consolidated Statements of Stockholders? HTML 101K
Equity
22: R7 Consolidated Statements of Cash Flows HTML 135K
23: R8 Organization and Basis of Presentation HTML 33K
24: R9 Summary of Significant Accounting Policies HTML 122K
25: R10 Short-Term Investments HTML 77K
26: R11 Composition of Certain Financial Statement Items HTML 70K
27: R12 Fair Value Measurements HTML 70K
28: R13 Leases HTML 67K
29: R14 Debt HTML 60K
30: R15 Stockholders' Equity HTML 140K
31: R16 Employee Benefits HTML 29K
32: R17 Income Taxes HTML 111K
33: R18 Business Segment and Geographic Information HTML 45K
34: R19 Acquisitions HTML 33K
35: R20 Commitments and Contingencies HTML 33K
36: R21 Fourth Quarter Financial Data (Unaudited) HTML 40K
37: R22 Subsequent Event HTML 28K
38: R23 Organization and Basis of Presentation (Policies) HTML 125K
39: R24 Summary of Significant Accounting Policies HTML 97K
(Tables)
40: R25 Short-Term Investments (Tables) HTML 76K
41: R26 Composition of Certain Financial Statement Items HTML 78K
(Tables)
42: R27 Fair Value Measurements (Tables) HTML 65K
43: R28 Leases (Tables) HTML 60K
44: R29 Debt (Tables) HTML 44K
45: R30 Stockholders' Equity (Tables) HTML 139K
46: R31 Income Taxes (Tables) HTML 110K
47: R32 Business Segment and Geographic Information HTML 38K
(Tables)
48: R33 Fourth Quarter Financial Data (Unaudited) (Tables) HTML 39K
49: R34 Organization and Basis of Presentation (Details) HTML 30K
50: R35 Summary of Significant Accounting Policies - HTML 67K
Additional Information (Details)
51: R36 Summary of Significant Accounting Policies - HTML 43K
Customers Accounted for 10% or More (Detail)
52: R37 Summary of Significant Accounting Policies - HTML 42K
Reconciliation of Change in Estimated Warranty
Liabilities (Details)
53: R38 Summary of Significant Accounting Policies - HTML 56K
Numerator and Denominator of the Basic and Diluted
Net Income (Loss) Per Share Computations (Details)
54: R39 Summary of Significant Accounting Policies - HTML 42K
Anti-Dilutive Securities (Details)
55: R40 Short-Term Investments - Estimated Fair Value of HTML 52K
Short-Term Investments (Details)
56: R41 Short-Term Investments - Contractual Maturities of HTML 48K
Available - For- Sale Debt Securities (Details)
57: R42 Composition of Certain Financial Statement Items - HTML 35K
Accounts Receivable (Details)
58: R43 Composition of Certain Financial Statement Items - HTML 34K
Reconciliation of Change in Estimated Allowance
for Doubtful Accounts (Details)
59: R44 Composition of Certain Financial Statement Items - HTML 34K
Inventory (Details)
60: R45 Composition of Certain Financial Statement Items - HTML 43K
Summary of Property and Equipment (Detail)
61: R46 Composition of Certain Financial Statement Items - HTML 36K
Additional Information (Detail)
62: R47 Composition of Certain Financial Statement Items - HTML 35K
Intangible Assets Subject to Amortization
(Details)
63: R48 Fair Value Measurements - Financial Assets and HTML 84K
Liabilities Measured at Fair Value on Recurring
Basis (Details)
64: R49 Leases - Additional Information (Details) HTML 97K
65: R50 Leases - Lease Cost, Lease Term Discount Rate, HTML 39K
Operating Leases (Details)
66: R51 Leases - Future Minimum Payments Under HTML 49K
Non-cancellable Operating Leases (Details)
67: R52 Leases - Lease Payments (Details) HTML 31K
68: R53 Debt - Additional Information (Details) HTML 127K
69: R54 Debt - Components of Convertible Note (Details) HTML 44K
70: R55 Debt - Interest Expense Recognized (Details) HTML 46K
71: R56 Stockholders' Equity -Shares of Common Stock HTML 51K
Reserved for Future Issuance (Details)
72: R57 Stockholders' Equity - Common Stock Warrants HTML 39K
(Details)
73: R58 Stockholders' Equity - Additional Information HTML 101K
(Details)
74: R59 Stockholders' Equity - Summary of Stock Option HTML 81K
Activities for 2006 Plan and 2013 Plan (Detail)
75: R60 Stockholders' Equity - Restricted Stock Units HTML 61K
(RSUs) (Details)
76: R61 Stockholders' Equity - Assumptions Used in HTML 54K
Black-Scholes Option-Pricing Model (Details)
77: R62 Stockholders' Equity - Allocation of Stock-Based HTML 43K
Compensation Expense (Details)
78: R63 Employee Benefits - Additional Information HTML 29K
(Details)
79: R64 Income Taxes - Income (Loss) Before Provision for HTML 36K
Income Taxes (Details)
80: R65 Income Taxes - Schedule of Components of Income HTML 54K
Tax (Details)
81: R66 Income Taxes - Income Tax Expense (Details) HTML 53K
82: R67 Income Taxes - Additional Information (Details) HTML 62K
83: R68 Income Taxes - Schedule of Deferred Tax Assets and HTML 57K
Liabilities (Details)
84: R69 Income Taxes - Schedule of Unrecognized Tax HTML 36K
Benefits (Detail)
85: R70 Business Segment and Geographic Information - HTML 38K
Additional Information (Details)
86: R71 Business Segment and Geographic Information - HTML 38K
Geographical Markets (Details)
87: R72 Acquisitions (Details) HTML 54K
88: R73 Commitments and Contingencies (Details) HTML 31K
89: R74 Fourth Quarter Financial Data (Unaudited) (Detail) HTML 74K
90: R9999 Uncategorized Items - tndm-20231231.htm HTML 45K
92: XML IDEA XML File -- Filing Summary XML 166K
95: XML XBRL Instance -- tndm-20231231_htm XML 2.12M
91: EXCEL IDEA Workbook of Financial Report Info XLSX 184K
12: EX-101.CAL XBRL Calculations -- tndm-20231231_cal XML 255K
13: EX-101.DEF XBRL Definitions -- tndm-20231231_def XML 631K
14: EX-101.LAB XBRL Labels -- tndm-20231231_lab XML 1.94M
15: EX-101.PRE XBRL Presentations -- tndm-20231231_pre XML 1.15M
11: EX-101.SCH XBRL Schema -- tndm-20231231 XSD 182K
93: JSON XBRL Instance as JSON Data -- MetaLinks 571± 871K
94: ZIP XBRL Zipped Folder -- 0001438133-24-000028-xbrl Zip 918K
The following is a summary of all material characteristics of the capital stock of Tandem Diabetes Care, Inc., as set forth in our Amended and Restated Certificate of Incorporation, as amended, or our Charter, and our Amended and Restated Bylaws, as amended, or our Bylaws. References
to "we,""us," and "our" refer to Tandem Diabetes Care, Inc. The summary does not purport to be complete and is qualified in its entirety by reference to our Charter and Bylaws, copies of which have been filed as exhibits to our public filings with the Securities and Exchange Commission.
Common Stock
General. We may issue shares of our common stock from time to time. We are authorized to issue 200,000,000 shares of common stock, par value $0.001 per share.
Dividend Rights. Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of outstanding
shares of our common stock are entitled to receive dividends out of funds legally available at the times and in the amounts that our board of directors may determine.
Voting Rights. Holders of our common stock are entitled to one vote per share. We have not provided for cumulative voting for the election of directors in our Charter. Each director is elected annually at each year’s annual meeting of stockholders.
No Preemptive or Similar Rights. Our common stock is not entitled to preemptive rights, and is not subject to redemption. There are no sinking fund provisions applicable to our common stock.
Conversion. Our common stock is not convertible into any other
shares of our capital stock.
Right to Receive Liquidation Distributions. Upon our liquidation, dissolution, distribution of assets or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our common stock and any participating preferred stock outstanding at that time, if any, after payment of liquidation preferences, if any, on any outstanding shares of preferred stock and payment of claims of creditors.
Preferred Stock
Pursuant to the terms of our Charter, our board of directors is authorized, subject to limitations prescribed by Delaware law, to issue up to 5,000,000 shares of preferred stock, par value $0.001 per share, in one or more series, to establish
from time to time the number of shares to be included in each series, and to fix the designation, powers, preferences and rights of the shares of each series and any of its qualifications, limitations or restrictions, in each case without further action by our stockholders. Our board of directors also can increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding. Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in our control or the removal of management and could adversely affect the market price of our common stock and
the voting and other rights of the holders of our common stock.
The Delaware General Corporation Law, or the DGCL, provides that the holders of preferred stock will have the right to vote separately as a class on any proposed fundamental change in the rights of the preferred stock. This right is in addition to any voting rights that may be provided for in the applicable certificate of designation.
Exhibit 4.2
Delaware Law and Certain Charter and Bylaw Provisions
The provisions of Delaware law, as well as certain terms
of our Charter and Bylaws, may have the effect of delaying, deferring or discouraging another person from acquiring control of us by means of a tender offer, a proxy contest or otherwise, or removing incumbent officers and directors. These provisions, some of which are summarized below, are expected to discourage certain types of coercive takeover practices and takeover bids that our board of directors may consider inadequate and to encourage any person seeking to acquire control of us to first negotiate with our board of directors.
Delaware Law. We are governed by the provisions of Section 203 of the DGCL. In general, Section 203 prohibits a public Delaware corporation from engaging in a “business combination” with an “interested stockholder” for a period of three
years after the date such stockholder became an “interested stockholder.” A “business combination” includes mergers, asset sales or other transactions resulting in a financial benefit to the stockholder. An “interested stockholder” is a person who, together with affiliates and associates, owns, or within three years did, prior to the determination of interested stockholder status, own, 15% or more of the corporation’s outstanding voting stock.
Charter and Bylaw Provisions. Our Charter and Bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our management team, including the following:
•Issuance
of Undesignated Preferred Stock. Our board of directors will have the authority, without further action by our stockholders, to issue up to 5,000,000 shares of undesignated preferred stock with rights and preferences designated from time to time by our board of directors. Our board of directors may utilize such shares for a variety of corporate purposes. See the section entitled “Preferred Stock”.
•Stockholder Action; Special Meeting of Stockholders. Our Charter eliminates the right of stockholders to act by written consent. Our Charter further provides that special meetings of our stockholders may be called only by a majority of our board of directors.
•Advance Notice Requirements for Stockholder
Proposals and Director Nominations. Our Charter and Bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders, or to nominate candidates for election as directors at our annual meeting of stockholders.
•Amendment. Our Charter and Bylaws provide that the affirmative vote of the holders of at least 66 2/3% of our voting stock then outstanding is required to amend certain provisions.
•Size of Board and Vacancies. Our Charter and Bylaws
provide that the number of directors on our board of directors is fixed exclusively by our board of directors. Newly created directorships resulting from any increase in our authorized number of directors, and any vacancies resulting from death, resignation, retirement, disqualification, removal from office or other cause, will generally be filled by a majority of our board of directors then in office.
•No Cumulative Voting. The DGCL provides that stockholders are denied the right to cumulate votes in the election of directors unless our Charter provides otherwise. Our Charter does not provide for cumulative voting.
